MPW
GILD icon

MASECO Private Wealth’s Gilead Sciences GILD Stock Holding History

MASECO Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27
Closed -$3.79K – 338
2026
Q1 		$3.79K Hold
27
– – ﹤0.01% 306
2025
Q4 		$3.34K Buy
+27
New +$3.28K ﹤0.01% 451
2025
Q3 		– Sell
-27
Closed -$3.01K – 366
2025
Q2 		$3.01K Buy
+27
New +$2.87K ﹤0.01% 430

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MASECO Private Wealth's GILD Position: Q2 2026 in Review

MASECO Private Wealth sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 27 shares — an estimated $3.79K sold.

MASECO Private Wealth first reported a position in GILD in Q2 2025 and held it in 3 quarters. The position peaked at $3.79K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MASECO Private Wealth reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • MASECO Private Wealth sold 27 Gilead Sciences shares in Q2 2026, an estimated $3.79K.
  • MASECO Private Wealth first reported a position in Gilead Sciences in Q2 2025 and held it in 3 quarters.
  • MASECO Private Wealth's Gilead Sciences position peaked at $3.79K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.